Clinical trial
Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult…
NCT00117377 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00117377 |
|---|---|
| Title | Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis |
| Official title | Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus, Placebo |
| Enrollment | 70 |
| Start date | Apr 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jul 6, 2005 |
| Last update posted | Dec 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: